# OnCo record paper-aramis-nejm-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aramis-nejm-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aramis-nejm-2019" ;
  schema:name "ARAMIS: darolutamide in non-metastatic castration-resistant prostate cancer"@en ;
  schema:description "Darolutamide, an androgen receptor inhibitor that barely enters the brain, delayed metastases by nearly two years in men with non-metastatic castration-resistant prostate cancer with side effects close to placebo, and later showed a survival benefit."@en ;
  schema:url <https://onco.cc/key-papers/paper-aramis-nejm-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1815671>, <https://pubmed.ncbi.nlm.nih.gov/30763142/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1815671> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Fizazi K, Shore N, Tammela TL, et al." ;
  onco:cancers <https://onco.cc/cancers/prostate-nmcrpc/> ;
  onco:drugs <https://onco.cc/drugs/darolutamide/> ;
  onco:trials <https://onco.cc/trials/aramis/> ;
  onco:journals <https://onco.cc/journals/nejm/> .